Close Menu

NEW YORK (GenomeWeb) – Cowen, Leerink, and JP Morgan have initiated coverage of immunoassay firm Quanterix.

Cowen and Leerink both gave the company an Outperform rating with the former giving no price target and the latter a price target of $27. JP Morgan initiated coverage with an Overweight rating and a price target of $24.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
17
Sponsored by
Isoplexis

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.